Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.08T
Market cap1.08T
Price-Earnings ratio
41.36
Price-Earnings ratio41.36
Dividend yield
0.56%
Dividend yield0.56%
Average volume
3.52M
Average volume3.52M
High today
$1,182.73
High today$1,182.73
Low today
$1,143.60
Low today$1,143.60
Open price
$1,155.51
Open price$1,155.51
Volume
4.50M
Volume4.50M
52 Week high
$1,182.73
52 Week high$1,182.73
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 1.08T, Eli Lilly(LLY) trades at $1,159.95. The stock has a price-to-earnings ratio of 41.36 and currently yields dividends of 56.2%.

On 2026-06-09, Eli Lilly(LLY) stock moved within a range of $1,143.60 to $1,182.73. With shares now at $1,159.95, the stock is trading +1.4% above its intraday low and -1.9% below the session's peak.

Trading activity shows a volume of 4.5M, compared to an average daily volume of 3.52M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,182.73 and a low of $623.78.

LLY News

Reuters 3h
Roche sticks to German investment after Eli Lilly cuts - Reuters

...

Roche sticks to German investment after Eli Lilly cuts - Reuters
Nasdaq 9h
Why Eli Lilly Stock Climbed to a New All-Time High Today

Key Points Investors are excited about retatrutide's potential. Rival drugmakers are finding it difficult to keep pace with the healthcare leader. 10 stocks...

Why Eli Lilly Stock Climbed to a New All-Time High Today
Nasdaq 13h
Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy?

Key Points Prevention could become Eli Lilly's next multibillion-dollar growth driver. Antibiotic resistance is increasing demand for preventive vaccine solut...

Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy?

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

Nasdaq 18h
A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.

Key Points Zealand Pharma reported a high drop-out rate in a phase III trial of Survodutide, due to undesirable side effects experienced by patients. That's g...

A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.
TipRanks 18h
Lilly Advances Early-Stage Asset With Completion of LY4064809 Bioavailability Study

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. This Phase 1 study, officially titled “A Phase 1, Open-label Study of the Abso...

Investor's Business Daily 19h
Big Pharma Stock Eli Lilly Concocts New Buy Zone

Eli Lilly Leads Medical Stocks To Watch, While Google Finds Support 6/06/2026 Eli Lilly leads three health care stocks to watch as the market appears to be rot...

Big Pharma Stock Eli Lilly Concocts New Buy Zone
TipRanks 20h
Eli Lilly Stock Jumps 4%. The Outlook for Its Weight-Loss Drugs Just Keeps Getting Better

The stock of Eli Lilly (LLY) is up 4% on June 8 following positive trial data for the company’s newest weight-loss drug called Retatrutide. Unlock trusted, dat...

CNBC 20h
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

Key Points Novo Nordisk and Eli Lilly are introducing GLP-1 pills for obesity, and that competition was on display this weekend at the American Diabetes Associa...

Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Benzinga 20h
Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages

Eli Lilly and Co. (NYSE:LLY) on Sunday presented new analyses showing that women with obesity or overweight achieved significant weight loss with Foundayo acros...

Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages
TipRanks 20h
‘This Is Compelling’: Citi Pounds the Table on Eli Lilly Stock

Eli Lilly (NYSE:LLY) shares are getting the thumbs up from investors on Monday after new data on its next-generation obesity therapy retatrutide strengthened co...

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.